Tredegar
Corporation
|
(Exact
Name of Registrant as Specified in its
Charter)
|
Virginia
|
1-10258
|
54-1497771
|
(State
or Other Jurisdiction
of
Incorporation)
|
(Commission
File
Number)
|
(IRS
Employer
Identification
No.)
|
1100
Boulders Parkway
Richmond,
Virginia
|
23225
|
|
(Address
of Principal Executive Offices)
|
(Zip
Code)
|
o |
Written
communications pursuant to Rule 425 under the Securities Act (17
CFR
230.425)
|
o |
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
|
o |
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17
CFR
240.14d-2(b))
|
o |
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17
CFR
240.13e-4(c))
|
3.2
|
Amended
and Restated By-laws of Tredegar Corporation, as of November 5,
2007.
|
99 | Press Release, dated November 5, 2007 (furnished pursuant to Item 2.02). |
TREDEGAR CORPORATION | ||
|
|
|
Date: November 6, 2007 | By: | /s/ D. Andrew Edwards |
D. Andrew Edwards |
||
Vice President, Chief Financial Officer and Treasurer |
EXHIBIT
|
DESCRIPTION
|
3.2 | Amended and Restated By-laws of Tredegar Corporation, as of November 5, 2007. |
99 | Press Release, dated November 5, 2007 (furnished pursuant to Item 2.02). |
Tredegar
Corporation
|
Contact:
|
|
Corporate
Communications
|
D.
Andrew Edwards
|
|
1100
Boulders Parkway
|
Phone:
804/330-1041
|
|
Richmond,
Virginia 23225
|
Fax:
804/330-1777
|
|
E-mail:
invest@tredegar.com
|
E-mail:
daedward@tredegar.com
|
|
Web
Site: www.tredegar.com
|
(In
Millions, Except Per-S hare Data)
|
Three
Months Ended
September
30
|
Nine
Months Ended
September
30
|
|||||||||||
|
2007
|
2006
|
2007
|
2006
|
|||||||||
Sales
|
$
|
275.7
|
$
|
296.3
|
$
|
836.9
|
$
|
846.7
|
|||||
Net
income (loss) as reported under ge nerally acc epte d
accounting
principles (GAAP)
|
$
|
(18.4
|
)
|
$
|
9.7
|
$
|
1.9
|
$
|
27.2
|
||||
After-tax
effects of:
Loss
associated with plant shutdowns, asset
impairments
and re struc turing s:
Asset
impairment relating to aluminum extrusion
operations
in Canada
|
22.7
|
-
|
22.7
|
-
|
|||||||||
Other
|
3.6
|
1.0
|
4.2
|
2.9
|
|||||||||
(Gains)
losses from sale of assets and other items
|
-
|
(0.7
|
)
|
(0.7
|
)
|
(1.6
|
)
|
||||||
Income
from manufacturing operations*
|
$
|
7.9
|
$
|
10.0
|
$
|
28.1
|
$
|
28.5
|
|||||
Diluted
earnings (loss) per share as reported under GAAP
|
$
|
(0.47
|
)
|
$
|
0.25
|
$
|
0.05
|
$
|
0.70
|
||||
After-tax
effects per diluted share of:
Loss
associated with plant shutdowns, asset
impairments
and re struc turing s:
Asset
impairment relating to aluminum extrusion
operations
in Canada
|
0.58
|
-
|
0.58
|
-
|
|||||||||
Other
|
0.09
|
0.03
|
0.10
|
0.07
|
|||||||||
(Gains)
losses from sale of assets and other items
|
-
|
(0.02
|
)
|
(0.02
|
)
|
(0.04
|
)
|
||||||
Diluted
earnings per share from manufacturing operations*
|
$
|
0.20
|
$
|
0.26
|
$
|
0.71
|
$
|
0.73
|
Condensed
Consolidated Statements of Income
|
(In
Thousands, Except Per-Share Data)
|
(Unaudited)
|
Third
Quarter Ended
|
Nine
Months Ended
|
||||||||||||
September
30
|
September
30
|
||||||||||||
2007
|
2006
|
2007
|
2006
|
||||||||||
Sales
|
$
|
275,726
|
$
|
296,256
|
$
|
836,902
|
$
|
846,711
|
|||||
Other
income (expense), net (a) (b)
|
(1,987
|
)
|
474
|
(1,533
|
)
|
734
|
|||||||
273,739
|
296,730
|
835,369
|
847,445
|
||||||||||
Cost
of goods sold (a)
|
234,314
|
252,848
|
712,236
|
719,177
|
|||||||||
Freight
|
6,477
|
7,265
|
19,100
|
20,989
|
|||||||||
Selling,
R&D and general expenses
|
20,173
|
20,151
|
58,724
|
56,684
|
|||||||||
Amortization
of intangibles
|
37
|
37
|
112
|
112
|
|||||||||
Interest
expense
|
628
|
1,331
|
2,009
|
4,231
|
|||||||||
Asset
impairments and costs associated with exit and
|
|||||||||||||
disposal
activities (a)
|
29,324
|
692
|
30,182
|
3,410
|
|||||||||
290,953
|
282,324
|
822,363
|
804,603
|
||||||||||
Income
(loss) before income taxes
|
(17,214
|
)
|
14,406
|
13,006
|
42,842
|
||||||||
Income
taxes (b)
|
1,162
|
4,716
|
11,114
|
15,687
|
|||||||||
Net
income (loss) (a) (b) (c)
|
$
|
(18,376
|
)
|
$
|
9,690
|
$
|
1,892
|
$
|
27,155
|
||||
Earnings
(loss) per share:
|
|||||||||||||
Basic
|
$
|
(.47
|
)
|
$
|
.25
|
$
|
.05
|
$
|
.70
|
||||
Diluted
|
(.47
|
)
|
.25
|
.05
|
.70
|
||||||||
Shares
used to compute earnings (loss) per share:
|
|||||||||||||
Basic
|
38,985
|
38,654
|
39,219
|
38,629
|
|||||||||
Diluted
|
38,985
|
39,123
|
39,396
|
38,876
|
|||||||||
Tredegar
Corporation
|
Net
Sales and Operating Profit by Segment
|
(In
Thousands)
|
(Unaudited)
|
Third
Quarter Ended
|
Nine
Months Ended
|
||||||||||||
September
30
|
September
30
|
||||||||||||
2007
|
2006
|
2007
|
2006
|
||||||||||
Net
Sales
|
|||||||||||||
Film
Products
|
$
|
134,065
|
$
|
134,961
|
$
|
400,385
|
$
|
382,697
|
|||||
Aluminum
Extrusions
|
135,184
|
154,030
|
417,417
|
443,025
|
|||||||||
Total
net sales
|
269,249
|
288,991
|
817,802
|
825,722
|
|||||||||
Add
back freight
|
6,477
|
7,265
|
19,100
|
20,989
|
|||||||||
Sales
as shown in the Consolidated
|
|||||||||||||
Statements
of Income
|
$
|
275,726
|
$
|
296,256
|
$
|
836,902
|
$
|
846,711
|
|||||
Operating
Profit
|
|||||||||||||
Film
Products:
|
|||||||||||||
Ongoing
operations
|
$
|
15,926
|
$
|
13,770
|
$
|
46,508
|
$
|
42,611
|
|||||
Plant
shutdowns, asset impairments and
|
|||||||||||||
restructurings,
net of gains on sale of assets and
|
|||||||||||||
related
income from LIFO inventory liquidations (a)
|
-
|
1,022
|
(393
|
)
|
207
|
||||||||
Aluminum
Extrusions:
|
|||||||||||||
Ongoing
operations
|
1,131
|
5,407
|
7,885
|
15,947
|
|||||||||
Plant
shutdowns, asset impairments and
|
|||||||||||||
restructurings
(a)
|
(28,146
|
)
|
(920
|
)
|
(28,245
|
)
|
(1,434
|
)
|
|||||
|
|||||||||||||
AFBS
(d):
|
|||||||||||||
Loss
on investment in Therics, LLC
|
-
|
-
|
-
|
(25
|
)
|
||||||||
Plant
shutdowns, asset impairments and
|
|||||||||||||
restructurings
(a)
|
(1,220
|
)
|
(494
|
)
|
(1,586
|
)
|
(494
|
)
|
|||||
Total
|
(12,309
|
)
|
18,785
|
24,169
|
56,812
|
||||||||
Interest
income
|
289
|
315
|
960
|
822
|
|||||||||
Interest
expense
|
628
|
1,331
|
2,009
|
4,231
|
|||||||||
Gain
on the sale of corporate assets (b)
|
-
|
-
|
-
|
56
|
|||||||||
Loss
from write-down of an investment (b)
|
2,095
|
-
|
2,095
|
-
|
|||||||||
Stock
option-based compensation costs (e)
|
236
|
215
|
701
|
708
|
|||||||||
Corporate
expenses, net
|
2,235
|
3,148
|
7,318
|
9,909
|
|||||||||
Income
(loss) before income taxes
|
(17,214
|
)
|
14,406
|
13,006
|
42,842
|
||||||||
Income
taxes (b)
|
1,162
|
4,716
|
11,114
|
15,687
|
|||||||||
Net
income (loss) (a) (b) (c)
|
$
|
(18,376
|
)
|
$
|
9,690
|
$
|
1,892
|
$
|
27,155
|
||||
Tredegar
Corporation
|
Condensed
Consolidated Balance Sheets
|
(In
Thousands)
|
(Unaudited)
|
September
30,
|
December
31,
|
||||||
2007
|
2006
|
||||||
Assets
|
|||||||
Cash
& cash equivalents
|
$
|
38,946
|
$
|
40,898
|
|||
Accounts
& notes receivable, net
|
143,689
|
121,834
|
|||||
Income
taxes recoverable
|
4,003
|
10,975
|
|||||
Inventories
|
64,890
|
68,930
|
|||||
Deferred
income taxes
|
7,693
|
6,055
|
|||||
Prepaid
expenses & other
|
3,801
|
4,558
|
|||||
Total
current assets
|
263,022
|
253,250
|
|||||
Property,
plant & equipment, net
|
288,680
|
325,763
|
|||||
Other
assets (f)
|
87,556
|
64,078
|
|||||
Goodwill
& other intangibles
|
141,848
|
138,696
|
|||||
Total
assets
|
$
|
781,106
|
$
|
781,787
|
|||
Liabilities
and Shareholders' Equity
|
|||||||
Accounts
payable
|
$
|
94,120
|
$
|
69,426
|
|||
Accrued
expenses
|
39,431
|
41,906
|
|||||
Current
portion of long-term debt
|
638
|
678
|
|||||
Total
current liabilities
|
134,189
|
112,010
|
|||||
Long-term
debt
|
43,515
|
61,842
|
|||||
Deferred
income taxes
|
78,784
|
75,772
|
|||||
Other
noncurrent liabilities (f)
|
17,237
|
15,568
|
|||||
Shareholders'
equity (f)
|
507,381
|
516,595
|
|||||
Total
liabilities and shareholders' equity
|
$
|
781,106
|
$
|
781,787
|
|||
Tredegar
Corporation
|
Condensed
Consolidated Statement of Cash Flows
|
(In
Thousands)
|
(Unaudited)
|
Nine
Months Ended
|
|||||||
September
30
|
|||||||
2007
|
2006
|
||||||
Cash
flows from operating activities:
|
|||||||
Net
income (loss)
|
$
|
1,892
|
$
|
27,155
|
|||
Adjustments
for noncash items:
|
|||||||
Depreciation
|
34,440
|
32,619
|
|||||
Amortization
of intangibles
|
112
|
112
|
|||||
Deferred
income taxes
|
(6,691
|
)
|
10,135
|
||||
Accrued
pension income and postretirement benefits
|
(1,297
|
)
|
2,358
|
||||
Gain
on sale of assets
|
-
|
(56
|
)
|
||||
Loss
on asset impairments and divestitures
|
29,983
|
1,150
|
|||||
Changes
in assets and liabilities, net of effects of acquisitions
|
|||||||
and
divestitures:
|
|||||||
Accounts
and notes receivables
|
(15,880
|
)
|
(37,600
|
)
|
|||
Inventories
|
8,868
|
5,180
|
|||||
Income
taxes recoverable
|
6,972
|
2,353
|
|||||
Prepaid
expenses and other
|
886
|
870
|
|||||
Accounts
payable
|
18,124
|
25,109
|
|||||
Accrued
expenses
|
(3,333
|
)
|
7,877
|
||||
Other,
net
|
314
|
(938
|
)
|
||||
Net
cash provided by operating activities
|
74,390
|
76,324
|
|||||
Cash
flows from investing activities:
|
|||||||
Capital
expenditures
|
(15,919
|
)
|
(31,714
|
)
|
|||
Investments,
including Harbinger ($10 million), a drug delivery
|
|||||||
company
($6.5 million) and real estate ($5.7 million) in 2007
|
(22,631
|
)
|
(542
|
)
|
|||
Proceeds
from the sale of assets and property disposals &
|
|||||||
reimbursements
from customers for purchases of equipment
|
4,093
|
266
|
|||||
Net
cash used in investing activities
|
(34,457
|
)
|
(31,990
|
)
|
|||
Cash
flows from financing activities:
|
|||||||
Dividends
paid
|
(4,701
|
)
|
(4,656
|
)
|
|||
Debt
principal payments
|
(33,367
|
)
|
(38,956
|
)
|
|||
Borrowings
|
15,000
|
4,000
|
|||||
Repurchases
of Tredegar common stock, net of settlement
|
|||||||
payable
of $2,307
|
(26,705
|
)
|
-
|
||||
Proceeds
from exercise of stock options
|
6,470
|
1,162
|
|||||
Net
cash used in financing activities
|
(43,303
|
)
|
(38,450
|
)
|
|||
Effect
of exchange rate changes on cash
|
1,418
|
524
|
|||||
(Decrease)
increase in cash and cash equivalents
|
(1,952
|
)
|
6,408
|
||||
Cash
and cash equivalents at beginning of period
|
40,898
|
23,434
|
|||||
Cash
and cash equivalents at end of period
|
$
|
38,946
|
$
|
29,842
|
|||
Selected
Financial Measures
|
(In
Millions)
|
(Unaudited)
|
||||||||||
For
the Twelve Months Ended September 30, 2007
|
||||||||||
Film
|
Aluminum
|
|||||||||
Products
|
Extrusions
|
Total
|
||||||||
Operating
profit from ongoing operations
|
$
|
61.5
|
$
|
14.0
|
$
|
75.5
|
||||
Allocation
of corporate overhead
|
(8.6
|
)
|
(2.5
|
)
|
(11.1
|
)
|
||||
Add
back depreciation and amortization
|
33.3
|
12.7
|
46.0
|
|||||||
Adjusted
EBITDA (g)
|
$
|
86.2
|
$
|
24.2
|
$
|
110.4
|
||||
Selected
balance sheet and other data as of September 30, 2007:
|
||||||||||
Net
debt (cash) (h)
|
$
|
5.2
|
||||||||
Shares
outstanding
|
37.9
|
|||||||||
(a)
|
Plant
shutdowns, asset impairments and restructurings in the third quarter
of
2007 include:
|
Ÿ
|
A
pretax charge of $27.6 million for impairments of property, plant
and
equipment related to the aluminum extrusions
operations in Canada;
|
Ÿ
|
A
pretax charge of $1.2 million related to the estimated loss on
the
sub-lease of a portion of the AFBS (formerly Therics)
facility in Princeton, New Jersey;
|
Ÿ
|
A
pretax charge of $493,000 for severance and other employee-related
costs
in Aluminum Extrusions; and
|
Ÿ
|
A
pretax charge of $42,000 related to expected future environmental
costs at
the aluminum extrusions facility in Newnan, Georgia (included in
"Cost of
goods sold" in the condensed consolidated statements of income).
|
Ÿ
|
A
pretax charge of $27.6 million for impairments of property, plant
and
equipment related to the aluminum extrusions operations in
Canada;
|
Ÿ
|
A
pretax charge of $1.6 million related to the estimated loss on
the
sub-lease of a portion of the AFBS (formerly Therics) facility
in
Princeton, New Jersey;
|
Ÿ
|
A
pretax charge of $592,000 for severance and other employee-related
costs
in Aluminum Extrusions;
|
Ÿ
|
A
pretax charge of $42,000 related to expected future environmental
costs at
the aluminum extrusions facility in Newnan, Georgia (included in
"Cost of
goods sold" in the condensed consolidated statements of income).
|
Ÿ
|
A
net pretax gain of $1 million associated with the shutdown of the
films
manufacturing facility in LaGrange, Georgia, including a gain of
$1.2
million for related LIFO inventory liquidations (included in "Cost
of
goods sold" in the condensed consolidated statements of income),
partially
offset by other shutdown-related costs of
$198,000;
|
Ÿ
|
A
pretax charge of $920,000 related to expected future environmental
costs
at the aluminum extrusions facility in Newnan, Georgia (included
in "Cost
of goods sold" in the condensed consolidated statements of income);
and
|
Ÿ
|
A
pretax charge of $494,000 related to the estimated loss on the
sub-lease
of a portion of the AFBS (formerly Therics) facility in Princeton,
New
Jersey.
|
Ÿ
|
A
net pretax gain of $1.4 million associated with the shutdown of
the films
manufacturing facility in LaGrange, Georgia, including a gain of
$2.6
million for related LIFO inventory liquidations (included in "Cost
of
goods sold" in the condensed consolidated statements of income),
partially
offset by severance and other costs of $1 million and asset impairment
charges of $130,000;
|
Ÿ
|
Pretax
charges of $1 million for asset impairments in Film
Products;
|
Ÿ
|
A
pretax charge of $920,000 related to expected future environmental
costs
at the aluminum extrusions facility in Newnan, Georgia (included
in "Cost
of goods sold" in the condensed consolidated statements of
income);
|
Ÿ
|
Pretax
charges of $727,000 for severance and other employee-related costs
in
connection with restructurings in Film Products ($213,000) and
Aluminum
Extrusions ($514,000); and
|
Ÿ
|
A
pretax charge of $494,000 related to the estimated loss on the
sub-lease
of a portion of the AFBS (formerly Therics) facility in Princeton,
New
Jersey.
|
(b)
|
Gain
on the sale of corporate assets in 2006 includes a gain related
to the
sale of public equity securities.
|
(c)
|
Comprehensive
income (loss), defined as net income and other comprehensive income
(loss), was a loss of $12.2 million for the third quarter of 2007
and
income of $11.9 million for the third quarter of 2006. Comprehensive
income (loss) was income of $17 million for the first nine months
of 2007
and income of $32.2 million for the first nine months of 2006.
Other
comprehensive income (loss) includes changes in unrealized gains
and
losses on available-for-sale securities, foreign currency translation
adjustments, unrealized gains and losses on derivative financial
instruments and amortization of prior service cost and net gains
or losses
from pension and other postretirement benefit plans recorded net
of
deferred taxes directly in shareholders'
equity.
|
(d)
|
On
June 30, 2005, substantially all of the assets of AFBS, Inc. (formerly
Therics, Inc.), a wholly-owned subsidiary of Tredegar, were sold
or
assigned to a newly-created limited liability company, Therics,
LLC,
controlled and managed by an individual not affiliated with Tredegar.
AFBS
retained substantially all of its liabilities in the transaction,
which
included customary indemnification provisions for pre-transaction
liabilities. AFBS received a 17.5% equity interest in the new company
valued at $170,000 and a 3.5% interest in Theken Spine, LLC valued
at
$800,000, along with potential future payments on the sale of certain
products by Therics, LLC.
|
(e)
|
Effective
January 1, 2006, Tredegar adopted Statement of Financial Accounting
Standards (SFAS) No. 123(R), “Share-Based Payment” (SFAS 123(R)) using the
modified prospective method. SFAS 123(R) requires the company to
record
compensation expense for all share-based awards. Tredegar previously
applied Accounting Principles Board (APB) Opinion No. 25, “Accounting for
Stock Issued to Employees,” and related interpretations and provided the
required pro forma disclosures of SFAS No. 123, “Accounting for
Stock-Based Compensation” (SFAS 123). Prior periods were not
restated.
|
(f)
|
Effective
December 31, 2006, Tredegar adopted SFAS No. 158, “Employers' Accounting
for Defined Benefit Pension and Other Postretirement Plans” (SFAS 158).
This statement requires the recognition in the balance sheet of
the funded
status of each of our defined benefit pension and other postretirement
plans. Each overfunded plan is recognized as an asset and each
underfunded
plan is recognized as a liability. The initial impact of SFAS 158,
net of
deferred taxes, was recognized directly in shareholders' equity.
Adjustments from the new standard will not impact our debt covenant
computations since our credit agreement allows us to elect to use
generally accepted accounting principles in effect when the agreement
was
signed.
|
(g)
|
Adjusted
EBITDA for the twelve months ended September 30, 2007, represents
income
from continuing operations before interest, taxes, depreciation,
amortization, unusual items and losses associated with plant shutdowns,
asset impairments and restructurings, gains from the sale of assets,
investment write-down, charges related to stock option awards accounted
for under the fair value-based method and other items. Adjusted
EBITDA is
not intended to represent cash flow from operations as defined
by GAAP and
should not be considered as either an alternative to net income
(as an
indicator of operating performance) or to cash flow (as a measure
of
liquidity). Tredegar uses Adjusted EBITDA as a measure of unlevered
(debt-free) operating cash flow. We also use it when comparing
relative
enterprise values of manufacturing companies and when measuring
debt
capacity. When comparing the valuations of a peer group of manufacturing
companies, we express enterprise value as a multiple of Adjusted
EBITDA.
We believe Adjusted EBITDA is preferable to operating profit and
other
GAAP measures when applying a comparable multiple approach to enterprise
valuation because it excludes the items noted above, measures of
which may
vary among peer companies.
|
(h)
|
Net
debt is calculated as follows (in millions):
|
Debt
|
$
|
44.1
|
||
Less:
Cash and cash equivalents
|
(38.9
|
)
|
||
Net
debt
|
$
|
5.2
|